The Cancer Marker Profile Breast is designed to evaluate key tumour markers associated with breast cancer monitoring and risk assessment. Metropolis Healthcare uses advanced immunoassay technologies to deliver accurate insights that support diagnosis, treatment planning, and follow-up care.
Price:
Rs. 2,035.00
Sample Type: Serum
Fasting Not Requierd
Frequently Asked Questions (FAQ's):
What does the Cancer Marker Profile Breast include at Metropolis Healthcare?
It typically includes important breast cancer markers such as CA 15-3, CEA, and other relevant tumour indicators used for evaluation and monitoring.
How does Metropolis Healthcare perform this breast cancer marker test?
The panel is analysed using high-sensitivity immunoassays that detect and quantify tumour marker levels with precision.
Who should undergo the breast cancer marker profile at Metropolis Healthcare?
Patients under evaluation for breast cancer, those undergoing treatment, or individuals needing post-treatment monitoring may benefit from this panel.
How do these tumour markers help in breast cancer care?
They assist in assessing disease activity, monitoring response to therapy, and detecting potential recurrence.
Is this test used for early screening of breast cancer?
Tumour markers alone are not screening tools; Metropolis Healthcare recommends using them alongside imaging and clinical evaluation.
Is any preparation required before taking this test?
No fasting or special preparation is needed unless advised otherwise by your doctor.
How soon are results available from Metropolis Healthcare?
Results are generally available within a few working days, depending on the markers included.
Are the results reliable?
Yes. Metropolis Healthcare follows strict quality control measures and uses validated analytical platforms to ensure highly accurate results.